Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl made the following statement about the election of former Vice President Joe Biden:
“We are committed to working with the new administration and Congress to win the fight against COVID-19 and battle the most critical ongoing health challenges facing the United States and the world. Our nation and the world face an unprecedented public health crisis, and the research-based biopharmaceutical industry is working around the clock to develop therapeutics and vaccines to treat and prevent COVID-19.
“We look forward to working with policymakers and regulators to put COVID-19 behind us, to advance policies that lower patient costs and to sustain and protect a robust innovation ecosystem that makes it possible to develop new medicines.”